Skip to content

Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate in the Intensive Care Unit

Agreement Between Arterial, Central Venous, and Peripheral Venous Lactate in the Intensive Care Unit

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01624519
Enrollment
50
Registered
2012-06-20
Start date
2012-08-31
Completion date
2013-08-31
Last updated
2012-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Lactate Analysis

Keywords

Arterial Lactate, Central Venous Lactate, Peripheral Venous Lactate

Brief summary

The main objective of this study is to examine the agreement between arterial, central venous, and peripheral venous lactate values in a population of medical Intensive Care Unit (ICU) patients.

Detailed description

This study is a single-center, prospective trial to assess the agreement between arterial, central venous, and peripheral venous lactate measurements. When an arterial lactate is deemed to be necessary as part of ICU management, a central venous and peripheral venous sample will also obtained within 5 minutes. All of the samples will be analyzed using the same analyzer as quickly as possible. A maximum of 10 paired arterial and venous lactate samples will be obtained per patient to prevent a single patient from dominating the data set. Additional data collected on a standardized data collection form will include primary diagnosis, intubation status, use of inotropic agents, hypotension (defined as a systolic blood pressure \< 90 mm Hg), ICU length of stay and mortality. The Bland-Altman method will be used to assess agreement between arterial (A), central venous(CV), and peripheral venous (PV) lactate measurements. Approximately 50 patients will be enrolled in this study.

Interventions

PROCEDUREBlood Lactate Analysis

When an arterial lactate is deemed to be necessary as part of ICU management, a central venous and peripheral venous sample will also obtained within 5 minutes. All of the samples will be analyzed using the same analyzer as quickly as possible.

Sponsors

Olive View-UCLA Education & Research Institute
CollaboratorOTHER
University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients 18 years or older * Admitted to the Intensive Care Unit (ICU) * Determined by their treating clinicians to require both a central venous line and arterial line

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Agreement between peripheral venous, central venous, and arterial lactate values in a population of medical Intensive Care Unit (ICU) patients.1 year

Contacts

Primary ContactRichard Treger, MD
Rick.Treger@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026